Retatrutide UK status: it is not licensed and it cannot legally be sold. Retatrutide is an experimental weight loss medicine still in Phase 3 clinical trials. The MHRA has not approved it, so no UK pharmacy, doctor or clinic can legally supply it outside a clinical trial. Anything sold online as ‘retatrutide’ or ‘reta’ is unlicensed, and could be fake or contaminated.

Key facts
- Retatrutide is an investigational medicine made by Eli Lilly. It is not approved anywhere in the world.
- The MHRA says it cannot be legally supplied in the UK outside ongoing clinical trials.
- Lilly plans to ask the US regulator to approve it in early 2027. UK approval would come later still.
- The MHRA has raided illegal production sites in Northampton, Lincolnshire, Nottinghamshire and Northamptonshire.
- Licensed alternatives available now include Mounjaro, Wegovy (injection and tablet) and Foundayo, prescribed after a proper consultation.
What is retatrutide?
Retatrutide is an experimental weight loss medicine being developed by Eli Lilly, the company behind Mounjaro. It is a once-weekly injection that acts on three hormone receptors at once: GIP, GLP-1 and glucagon. That’s why you will see it called a “triple agonist”, or nicknamed “triple G” online. Mounjaro acts on two of these receptors (GIP and GLP-1). Wegovy acts on one (GLP-1).
Early trial results have created a lot of excitement. In Lilly’s TRIUMPH-1 trial, adults on the highest dose lost an average of around 28% of their body weight over 80 weeks. Lilly reported further positive Phase 3 results in July 2026. But promising trial results are not the same as a licence. Retatrutide is still being studied, and regulators have not yet weighed up its benefits against its risks.
Is retatrutide legal in the UK?
No. The Medicines and Healthcare products Regulatory Agency (MHRA) has said that retatrutide has not been authorised for medicinal use in the UK and cannot be legally supplied outside of ongoing clinical trials.
In practice, this means:
- No UK pharmacy, online doctor, aesthetic clinic or gym can legally sell or supply it.
- A prescriber cannot write a normal private prescription for it.
- Products sold as “retatrutide”, “reta” or “GLP-3” in the UK are illegal unlicensed medicines.
Eli Lilly itself states that retatrutide is an investigational molecule that cannot be legally sold or marketed for human use. In August 2026, Lilly filed lawsuits against US companies selling illegal versions.

Why is retatrutide being sold online?
Demand has arrived years before any approval decision. Trial headlines have spread quickly on social media, and illegal sellers have stepped in to fill the gap. Common sales routes include:
- Instagram, TikTok and Telegram accounts selling “reta pens”
- Fitness forums and gyms promoting it as a shortcut to “strip fat”
- Websites selling powdered “research peptides” labelled not for human consumption
- Beauty and aesthetics salons
None of these routes goes through the MHRA. There’s no purity testing, no check that the dose is accurate, no manufacturing standards, and no one to turn to if something goes wrong. Read our guide to why “research use only” peptides are dangerous for more on how these products are labelled.
What has the MHRA done about illegal retatrutide?
The MHRA’s Criminal Enforcement Unit regularly acts against illegal supply. According to the regulator, this has included raids on illegal manufacturing sites in:
- Northampton (October 2025), which the MHRA described as a record seizure of trafficked weight loss medicines
- Lincolnshire and Nottinghamshire (February 2026)
- Northamptonshire (May 2026)
Thousands of doses of weight loss medicines, including products labelled as retatrutide, were seized. We cover the raids in more detail in MHRA crackdown on illegal weight loss pens.
Important: the MHRA warns that there is no way of knowing what illegal products contain, whether they were made to proper standards, or how they were stored and transported. Some counterfeit weight loss pens have been found to contain insulin, which can cause dangerously low blood sugar.
What are the risks of using unlicensed retatrutide?
Even the genuine medicine is still being studied. In trials it caused common digestive side effects, an increase in heart rate, and an unusual skin-sensation side effect called dysaesthesia. On top of this, buying from an illegal seller adds risks of its own:
- Wrong ingredient: the product may contain a different drug, or nothing at all.
- Wrong dose: unregulated products are often under- or over-strength.
- Contamination: injectables made outside sterile conditions can cause infections and abscesses.
- No medical supervision: no one checks whether it’s safe for you, adjusts your dose or monitors side effects.
- No recourse: if you’re harmed, there’s no regulated pharmacy accountable for what you were supplied.
See retatrutide side effects for what the trials have shown so far.

When could retatrutide be approved in the UK?
Lilly has said it plans to submit retatrutide to the US Food and Drug Administration in the first quarter of 2027. The MHRA would carry out its own assessment. If it is approved, a NICE appraisal would follow to decide on NHS use. Realistically, legal private prescriptions in the UK look unlikely before late 2027 or 2028. Our retatrutide UK release date guide explains each step.
What can you use instead?
If you’re looking for medical help with weight loss, there are MHRA-licensed options available today, prescribed after a proper consultation:
| Treatment | Active ingredient | How it’s taken | Average weight loss in main trials |
|---|---|---|---|
| Mounjaro | Tirzepatide | Weekly injection | About 21% at 72 weeks (top dose) |
| Wegovy injection | Semaglutide | Weekly injection | About 15% (2.4mg) to 21% (7.2mg) |
| Wegovy pill | Semaglutide | Daily tablet | About 14–17% at 64 weeks |
| Foundayo | Orforglipron | Daily tablet | About 11–12% at 72 weeks |
These figures come from separate trials and can’t be compared directly. The right option depends on your health, your BMI, any other medicines you take and your own preferences. A prescriber can help you weigh these up; see our comparison of Mounjaro vs Wegovy or start a weight loss consultation.
How to make sure your treatment is legitimate
Before you buy any weight loss medicine online, check that:
- the pharmacy appears on the General Pharmaceutical Council (GPhC) register
- you have a real consultation, with your height and weight independently checked
- the medicine is a named, MHRA-licensed product dispensed by a UK pharmacy.
Our step-by-step guide shows you how to check an online pharmacy is registered.
Talk to a UK prescriber about your options
Complete a confidential online consultation. Our prescribers check your health history, independently verify your height and weight, and only recommend treatment if it is clinically appropriate for you.
Frequently asked questions
Can I buy retatrutide legally in the UK?
No. Retatrutide has no UK marketing authorisation, so it cannot be legally sold or supplied outside a clinical trial. Any website, social media account or gym selling it is operating illegally.
Is 'research grade' retatrutide legal?
Selling a product labelled ‘for research use only’ does not make it legal to supply for people to inject. The label is used to try to get around medicines law. These products have not been made or tested to medicine standards.
When will retatrutide be available in the UK?
Eli Lilly has said it plans to file for US approval in the first quarter of 2027. A UK decision would follow a separate MHRA review, so legal UK availability is unlikely before 2027–2028 at the earliest.
What should I do if I've already used retatrutide bought online?
Stop using it and speak to your GP or a pharmacist, especially if you’ve had side effects. You can report the product and any side effects to the MHRA through the Yellow Card scheme.
Is retatrutide stronger than Mounjaro?
Trial results suggest higher average weight loss, but no head-to-head trial with Mounjaro has reported yet and the full safety picture is still being studied. Until it is licensed, it is not an option for UK patients.
Related guides
Sources and further reading
- The Pharmacist – Warning over unlicensed weight-loss drugs being sold on social media (MHRA statement)
- Eli Lilly – Retatrutide successful in two additional Phase 3 obesity trials (23 July 2026)
- MHRA – GLP-1 medicines for weight loss and diabetes: what you need to know
- MHRA – Urges public to avoid illegal online weight-loss medicines
- GPhC – Check the register of pharmacies
This article is for general information and does not replace advice from your own doctor, pharmacist or prescriber. Prescription-only medicines are supplied only after a consultation shows they are clinically appropriate. Report suspected side effects to the MHRA Yellow Card scheme. Pills2U Ltd, GPhC registered pharmacy 9013275.
